mavacamten
bms
['hcm', 'rely', 'valor-hcm', 'mavacamten', 'ohcm', 'bmsnews', 'bms']
late breaking featured science at #aha2022 #valor-hcm 32-wk data w sustained benefit of mavacamten. 88% severely sympto ohcm no longer srt eligible after 32 wks. simult pub in 
Director, Clinical Ops, CVM, Director HCM Ctr, Med Dir Aortic Ctr, Haslam Family Endowed Chair, Professor of Medicine, Cleveland Clinic. Views mine not employer